Clinical trial
Fall Prevention by Alfacalcidol and Training
NCT00483275 · Ruhr University of Bochum, Other · Withdrawn
Key facts
| NCT number | NCT00483275 |
|---|---|
| Title | Fall Prevention by Alfacalcidol and Training |
| Official title | Effects of a Multi-modal 12-month-intervention With Alfacalcidol Plus Calcium, Patient Education and a Mobility Program on the Number of Fallers Among Patients With an Impaired Kidney Function Aged 65 and Older. |
| Acronym | SPALT |
| Lead sponsor | Ruhr University of Bochum, Other |
| Collaborators | Teva Branded Pharmaceutical Products R&D, Inc. Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Accidental Falls, Chronic Renal Insufficiency, Aged |
| Intervention type | Behavioral, Drug |
| Interventions | Alfacalcidol, Balance, gait and strength training, Patient education |
| Enrollment | 484 |
| Start date | Jun 1, 2007 |
| Completion | Sep 1, 2009 |
| First posted | Jun 7, 2007 |
| Last update posted | Jul 21, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: